Archive for the ‘Treatment’ Category

Lyme Disease Has Arrived. Why Hasn’t a Reliable Treatment?

https://www.theglobeandmail.com/opinion/article-lyme-disease-has-arrived-why-hasnt-a-reliable-treatment/

Until we know better how to diagnose and cure, we must do battle with ticks.  GETTY IMAGES/GETTY IMAGES

Mary Beth Pfeiffer, an investigative journalist from New York State, is author of Lyme: The First Epidemic of Climate Change.

Like soldiers in an advancing front, blacklegged ticks are today marching across Canada armed chiefly, but not solely, with a pathogen that indiscriminately sickens and disables: Lyme disease.

In 1990, ticks that carried the infection were found only in Long Point in far southern Ontario. But hitched to birds and enabled by a warmer climate, these blood-sucking arachnids have found a new and rich frontier across vast tracts of the country. They are in Ontario’s provincial parks, in Quebec’s Montérégie region, where temperatures have risen 0.8 degrees Celsius since 1970, along Manitoba’s Lake of the Woods, and in many parts of Nova Scotia, New Brunswick and British Columbia.

Climate change did not cause this scourge but it is surely abetting it. In Canada, white-footed mice that infect baby ticks when they take their first blood meal are also moving north, further setting the stage for the disease to grow.

 

The upshot: Canada is well into an epidemic that has exploded in the United States since the disease emerged in a small coastal town in Connecticut in the late 1970s. Today, these ticks reside in half of the continental United States’ 3,000 counties, twice the number of two decades ago. Evidence suggests that “case numbers will increase rapidly in the coming years in Canada as I. scapularis” – the blacklegged tick – “invades the most heavily populated southern parts of Canada,” according to a 2015 article in the journal Applied and Environmental Microbiology.

Of paramount concern amid this invasion is that the standard treatment for Lyme disease used in Canada and other countries – a short course of antibiotics – leaves a significant share of patients ill for weeks, months and sometimes years. This treatment is based on care guidelines developed in the United States that new research suggests are flawed. Until the medical establishment stops denying a problem exists, more people will suffer.

In the United States, authorities estimate that reported Lyme disease cases – 36,000 in 2016 – are one-10th of the actual number. Canada’s official disease count, which grew nearly sevenfold from 144 in 2009 to 992 in 2016, is also likely far below the real number. In a recent visit to Nova Scotia, the hardest-hit province, I frequently encountered people in restaurants and shops who shared stories of Lyme disease, suggesting the disease is more common than the 326 cases reported in 2016.

At this crucial juncture, Canadians would do well to learn from the mistakes of the U.S. model of Lyme disease care, which has cost patients dearly in delayed diagnoses and inadequate treatments. Since 2000, when the first treatment guidelines were issued in the United States, Lyme disease has been framed as an infection that is straightforward to both diagnose and treat. It is not.

Science has repeatedly found that the standard Lyme test fails to diagnose many infections – especially early in the disease, but later as well – leading to illness that is more difficult to treat. Moreover, some 10 per cent to 20 per cent of treated patients go on to suffer what American medicine calls “posttreatment Lyme disease syndrome,” a condition called “severe” in a recent Johns Hopkins University study. Symptoms may include muscle, bone and joint pain, memory and sleep disorders, fatigue, depression and neurological problems including numbness and tingling in hands and feet.

Beyond its early rash and flu-like symptoms, Lyme disease has also been linked to problems of balance, sight and cognition, facial palsy, meningitis, arthritic symptoms and, when the pathogen invades heart tissue, Lyme carditis.

In Canada, Britain, the Netherlands, Sweden, Germany and many other countries with Lyme disease, the U.S. guidelines have set the standard for – have essentially dictated – management of this epidemic. Yet, at least 20 scientific publications since 2012 have reported that the way Lyme disease is treated, with 10 to 28 days of antibiotics, may not be working. The pathogen survived in infected monkeys and mice and in test tubes when exposed to an array of antibiotics used in people.

Mainstream medicine has been slow to acknowledge and accept these new findings, clinging to dogma that a bottle of antibiotics cures. Extended antibiotic courses don’t always resolve advanced cases of Lyme disease. The problem is that medicine rejects the notion that Lyme lingers, so has done little to find treatments that work.

In research for a book on the global spread of ticks, I met patients who travelled across oceans and borders in search of care for intractable Lyme disease. I spoke to a woman from Thunder Bay, Ont., who drove 14 hours to bring her son to a doctor in New York State. Others included a British man who flew to California, a young Swedish woman who went to England and a Dutch woman who went to Belgium.

These are the patients whose tests failed to diagnose them; who did not get or see the variable reddish rash that signals infection; or who were inadequately treated. To be sure, a significant share of early treated patients recover. These are the patients around whom the dogma of Lyme treatment has been fashioned.

But thousands of other patients in hundreds of Lyme disease support groups around the world are testament to the failure of a faulty model of care. Canada should listen to them.

Medicine does not have a handle on this epidemic. What is controlling it now, to a far greater extent, are the environmental forces wrought by human influence over the planet.

As temperatures rise, ticks have moved poleward – into Scandinavia, Russia, China, even Siberia and Australia. There and here, they lurk where children play and outdoor laborers work and hikers brush against the edges of trails.

 

Until we know better how to diagnose and cure, we must do battle with ticks. Be vigilant to check our children after spending time outdoors; avoid tall grasses and leaf litter, and even consider chemical repellents and clothing treatments. We must recognize our role in enabling an eight-legged menace and a single-celled pathogen that for eons existed quietly in nature but that today wreak havoc for many.

_______________

**Comment**

A few things to ponder:

  • Ticks have been all over the place for decades but authorities have refused to believe & recognize it.  Sick patients & the doctors who dare to treat them are the proof in the pudding, but these sick people have repeatedly been denied diagnosis and treatment by mainstream medicine based on ancient, faulty testing and faulty maps supposedly showing where ticks are.

Ticks are all over the place:  https://madisonarealymesupportgroup.com/2017/10/06/remembering-dr-masters-the-rebel-for-lyme-patients-who-took-on-the-cdc-single-handedly/  This expose’ by Pam Weintraub shows Dr. Masters has been screaming bloody murder about a Lyme-like illness in the South for decades.  Crickets…..

https://madisonarealymesupportgroup.com/2016/09/24/arkansas-kids-denied-lyme-treatment/  It’s in Arkansas….crickets.

https://madisonarealymesupportgroup.com/2016/11/03/ld-not-in-australia-here-we-go-again/  A Lyme-like illness is in Australia……crickets.

https://madisonarealymesupportgroup.com/2018/02/06/lyme-in-the-southern-hemisphere-sexual-transmission/  It’s clearly in the Southern Hemisphere…..crickets.

As you can clearly see, this is about WAY MORE than testing and treatment.  It’s a collective disgrace that makes Pandora’s Box look like a cookie jar.

Time to roll up the sleeves and get to work because there’s a lot to do.

Image

Lyme & Other TBI’s – 3rd Rocky Mountain Forum – May 19, 2018

SaveTheDate2018

Decoding Neuro-Lyme Webinar – Dr. Rawls

https://rawlsmd.com/webinars/decoding-neurolyme/?

Decoding NeuroLyme: Live Webinar with Dr. Bill Rawls

Lyme disease can manifest in seemingly endless ways. But neurological symptoms such as brain fog, limb pain, muscle weakness, anxiety, and more can feel especially debilitating and difficult to diagnose, manage, and overcome.

So why are some people more likely to experience neurological Lyme disease — and what can you do to feel better? 

Join a live webinar with Dr. Bill Rawls, best-selling author of Unlocking Lyme, who knows firsthand what it’s like to live with chronic Lyme disease, as he demystifies neurological Lyme and offers an alternative view of causes and solutions.

You’ll learn how to take control of your health, and the essential steps for empowering your body’s natural defenses. 

PLUS: Don’t miss an exclusive special offer for webinar attendees, and have your questions ready for a LIVE Q&A on neurological Lyme disease with Dr. Rawls.

“Dr. Rawls is such a genuine resource in this bewildering Lyme maze. I appreciate you making his insights readily available.”  – David

Presented by Dr. Bill Rawls and Tim Yarborough

Wednesday, May 16th
8pm EDT

Webinar can be viewed on any device

RESERVE MY SEAT »

“Super helpful and informative. It was great to hear someone talk about this in a knowledgeable manner given that it seems like a mystery to so many others in the medical community. Thank you!” – Christian

In this webinar, Dr. Rawls will also discuss:
  • Why neurological symptoms such as cognitive impairment, nerve and limb pain, mood disruption, and more are so prevalent among Lyme sufferers
  • What causes these symptoms to become so overpowering in some people
  • Connections between neurological Lyme and other infections and chronic illnesses
  • Why conventional methods of diagnosis and treatment are limited and controversial
  • His holistic, restorative approach to creating a foundation of wellness

“Neurological symptoms are the most exasperating of all Lyme symptoms, because they disconnect you from the world at large. There is a path to recovery.” Dr. Rawls

 

Rheumatological Presentation of Bartonella Koehlerae & Henselae: A Case Report – Chiropractors Please Read!

https://journals.lww.com/mdjournal/Fulltext/2018/04270/Rheumatological_presentation_of_Bartonella.32.aspx

Rheumatological presentation of Bartonella koehlerae and Bartonella henselae bacteremias: A case report

Mozayeni, Bobak, Robert, MDa; Maggi, Ricardo, Guillermo, PhDb; Bradley, Julie, Meredith, BSb; Breitschwerdt, Edward, Bealmear, DVMb,*

Medicine: April 2018 – Volume 97 – Issue 17 – p e0465
doi: 10.1097/MD.0000000000010465
Research Article: Clinical Case Report

Abstract

Introduction: Systemic Bartonella spp. infections are being increasingly reported in association with complex medical presentations. Individuals with frequent arthropod exposures or animal contact appear to be at risk for acquiring long standing infections with Bartonella spp.

Case report: This case report describes infections with Bartonella koehlerae and Bartonella henselae in a female veterinarian whose symptoms were predominantly rheumatologic in nature. Infection was confirmed by serology, polymerase chain reaction (PCR), enrichment blood culture, and DNA sequencing of amplified B koehlerae and B henselae DNA. Long-term medical management with antibiotics was required to achieve elimination of these infections and was accompanied by resolution of the patient’s symptoms. Interestingly, the patient experienced substantial improvement in the acquired joint hypermobility mimicking Ehlers–Danlos Syndrome (EDS) type III.

Conclusion: To facilitate early and directed medical interventions, systemic bartonellosis should potentially be considered as a differential diagnosis in patients with incalcitrant rheumatological symptoms and frequent arthropod exposures or extensive animal contact.

____________

**Comment**

Bartonella isn’t even on most GP’s radars regarding tick borne illness, and in fact many deny ticks can even transmit it, yet here we see that those with arthropod exposure and/or animal contact need to consider it.  Isn’t that just about everyone under the sun?

You need to know this for yourself, friends and family.  Educate the doctors!

This poor female veterinarian was put on clindamycin & rifampin but had to discontinue after becoming pregnant.  She had a thousand symptoms:  axillary lymphadenopathy from cat scratch disease (CSD) at 12 years of age, a tibial sesamoid bone fracture, plantar fasciitis, generalized muscle/joint pain, muscle weakness, headaches, tingling, and fatigue, cervical lymph node enlargement, extremity edema, ligamentous laxity, tenosynovitis, shoulder and elbow subluxations, elbow joint crepitus, progressively worsening joint hypermobility (Beighton score 7/9), multiple joint subluxations daily, and breast cysts, meeting criteria for benign classification.

Please note the joint popping with each articulation and continual joint subluxation issue.  

Chiropractors need to be told about this.  Please educate!  Send them this article.

I too had this bizarre popping of the joints with a lot of instability in the knees.  Treatment completely ameliorated this issue so treatment is primo important.

For more on Bartonella:  https://madisonarealymesupportgroup.com/2016/01/03/bartonella-treatment/

https://madisonarealymesupportgroup.com/2018/05/07/fox-news-bartonella-is-the-new-lyme-disease/  (Tons more links on Bart after this article)

 

 

 

 

 

Lactoferrin for Lyme?

https://www.ncbi.nlm.nih.gov/pubmed/29669808

J Biol Chem. 2018 Apr 18. pii: jbc.RA118.003145. doi: 10.1074/jbc.RA118.003145. [Epub ahead of print]

Lactoferrin is a natural inhibitor of plasminogen activation.

Zwirzitz A1, Reiter M2, Skrabana R3, Ohradanova-Repic A2, Majdic O2, Gutekova M4, Cehlar O3, Petrovčíková E5, Kutejova E5, Stanek G2, Stockinger H6, Leksa V7.

Abstract
The plasminogen system is essential for dissolution of fibrin clots, and in addition, it is involved in a wide variety of other physiological processes, including proteolytic activation of growth factors, cell migration, and removal of protein aggregates. On the other hand, uncontrolled plasminogen activation contributes to many pathological processes, e.g. tumor cells’ invasion in cancer progression. Moreover, some virulent bacterial species, e.g. Streptococci or Borrelia, bind human plasminogen and hijack the host’s plasminogen system to penetrate tissue barriers. Thus, the conversion of plasminogen to the active serine protease plasmin must be tightly regulated. Here, we show that human lactoferrin, an iron-binding milk glycoprotein, blocks plasminogen activation on the cell surface by direct binding to human plasminogen. We mapped the mutual binding sites to the N-terminal region of lactoferrin, encompassed also in the bioactive peptide lactoferricin, and kringle 5 of plasminogen. Finally, lactoferrin blocked tumor cell invasion in vitro and also plasminogen activation driven by Borrelia. Our results explain many diverse biological properties of lactoferrin, and also suggest that lactoferrin may be useful as a potential tool for therapeutic interventions to prevent both invasive malignant cells and virulent bacteria from penetrating host tissues.

________

For More:  https://madisonarealymesupportgroup.com/2018/03/05/how-proteolytic-enzymes-may-help-lyme-msids/

https://madisonarealymesupportgroup.com/2016/04/22/systemic-enzymes/

https://madisonarealymesupportgroup.com/2018/01/03/the-invisible-universe-of-the-human-microbiome-msm/